These analysis were very very conservative. If the doctors play their cards right they can pull this acquisition for $600-$700K
This stock is far from going upside down. Even if they don't acquire this new company they can use the cash from issuing equity to strengthen their working capital position and with the new contracts in the pipe line ONCO should be profitable in a year even without this acquisition.
The way I see it it's win/win unless doctors screw up something.